1623 Capital’s DexCom DXCM Stock Holding History

1623 Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,272	Closed	-$425K	–	29
2022 Q3	$425K	Hold	5,272	–	–	0.26%	34
2022 Q2	$393K	Buy	5,272 +1,912	+57%	+$174K	0.25%	37
2022 Q1	$430K	Sell	3,360 -1,296	-28%	-$142K	0.22%	40
2021 Q4	$625K	Buy	4,656 +716	+18%	+$103K	0.23%	50
2021 Q3	$539K	Hold	3,940	–	–	0.21%	49
2021 Q2	$421K	Buy	3,940 +1,652	+72%	+$159K	0.16%	58
2021 Q1	$206K	Buy	+2,288	New	+$215K	0.08%	57

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

1623 Capital's DXCM Position: Q4 2022 in Review

1623 Capital sold out of DexCom (DXCM) in Q4 2022, closing a stake of 5,272 shares — an estimated $425K sold.

1623 Capital first reported a position in DXCM in Q1 2021 and held it in 7 quarters. The position peaked at $625K in Q4 2021. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

1623 Capital reported no remaining DexCom position as of Q4 2022 after selling out during the quarter.
1623 Capital sold 5,272 DexCom shares in Q4 2022, an estimated $425K.
1623 Capital first reported a position in DexCom in Q1 2021 and held it in 7 quarters.
1623 Capital's DexCom position peaked at $625K in Q4 2021.
920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on 1623 Capital's 13F filing for Q4 2022, filed 10 Feb 2023.